Rapid microbiology tests, also known as alternative microbiological methods, are the technologies that allow the user to get microbiology test results faster compared to the traditional culture-plate methods. Rapid microbiology testing provides qualitative, quantitative, and identification results. In the next few years the demand for rapid microbiology tests in pharmaceutical industry is expected to increase significantly in the emerging economies such as China and India.
The technology type studied for analyzing the overall rapid microbiology tests in pharmaceutical industry are into immunology based methods, nucleic acid amplification tests, mass spectrometry based methods, flow cytometry based methods, growth based detection technologies and biochemical tests. This report also highlights information about application segment in the pharmaceutical industry, such as raw material testing, in-process testing, microbial limit testing, bioburden assessment, process water testing, environmental monitoring, and sterility testing.
The global pharmaceutical rapid microbiology testing market is studied to understand screening of microorganisms in raw material, water and environment for production of pharmaceuticals and medical devices. The market segmentation of the global pharmaceutical rapid microbiology market includes by technology and application. The technology type is sub-segmented into immunology-based methods, nucleic acid based amplification (NASBA) mass spectrometry based methods, flow cytometry based methods, growth based detection technologies and biochemical tests. The growth-based detection technologies are further sub- segmented into ATP-bioluminescence, colorimeter detection, and auto-fluorescence detection. In terms of application the market is segmented into raw material testing, in-process testing, microbial limit testing, bio burden assessment, process water testing, environment monitoring and sterility testing. Technological advancements like the automated instruments for the identification of microbes and contaminating pathogens, rising prevalence of drug related adverse effects and allergic reactions, growing investment by market leaders in the research and development of microbiological and serological techniques, are the drivers that will facilitate the market growth of pharmaceutical rapid microbiological testing market.
Rapid microbiology tests, also known as alternative microbiological methods, are the technologies that allow the user to get microbiology test results faster compared to the traditional culture-plate methods. Conventional microbial analyses require extensive manual operations. In addition, the necessity for visual determination of the growth of microbial colonies leads to longer assay times. Rapid microbial tests provide faster results, but the key to acceptance is staying consistent with the compendial method. The global pharmaceutical rapid microbiology testing market have been broadly segmented into immunology based methods, nucleic acid amplification tests, mass spectrometry based methods, flow cytometry based methods, growth based detection technologies and biochemical tests. The nucleic acid amplification tests are further segmented into polymerase chain reaction, nucleic acid sequence-based amplification and others. Growth based detection technologies are further classified into ATP-bioluminescence, colorimeter detection and auto-fluorescence detection. Nucleic acid amplification tests based methods held the largest share in the rapid microbiology market due to its wide application in the pharmaceutical industry. Moreover, low cost and high speed would further fuel the market growth of immunology based methods.
Pharmaceutical rapid microbiological tests are gaining momentum in the global market as a reliable and cost-effective method to track and monitor all types of microorganisms in pharmaceutical industry settings. The applications in the global pharmaceutical rapid microbiology testing market is segmented into raw material testing, in-process testing, microbial limit testing, bio burden assessment, process water testing, environmental monitoring, and sterility testing. The raw material testing application held the largest share in the global pharmaceutical rapid microbiology testing market due its wide application in the final drug product and other applications. Sterility testing is anticipated to witness the fastest growth in the global pharmaceutical rapid microbiology testing market.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
This product will be delivered within 2 business days.
The technology type studied for analyzing the overall rapid microbiology tests in pharmaceutical industry are into immunology based methods, nucleic acid amplification tests, mass spectrometry based methods, flow cytometry based methods, growth based detection technologies and biochemical tests. This report also highlights information about application segment in the pharmaceutical industry, such as raw material testing, in-process testing, microbial limit testing, bioburden assessment, process water testing, environmental monitoring, and sterility testing.
The global pharmaceutical rapid microbiology testing market is studied to understand screening of microorganisms in raw material, water and environment for production of pharmaceuticals and medical devices. The market segmentation of the global pharmaceutical rapid microbiology market includes by technology and application. The technology type is sub-segmented into immunology-based methods, nucleic acid based amplification (NASBA) mass spectrometry based methods, flow cytometry based methods, growth based detection technologies and biochemical tests. The growth-based detection technologies are further sub- segmented into ATP-bioluminescence, colorimeter detection, and auto-fluorescence detection. In terms of application the market is segmented into raw material testing, in-process testing, microbial limit testing, bio burden assessment, process water testing, environment monitoring and sterility testing. Technological advancements like the automated instruments for the identification of microbes and contaminating pathogens, rising prevalence of drug related adverse effects and allergic reactions, growing investment by market leaders in the research and development of microbiological and serological techniques, are the drivers that will facilitate the market growth of pharmaceutical rapid microbiological testing market.
Rapid microbiology tests, also known as alternative microbiological methods, are the technologies that allow the user to get microbiology test results faster compared to the traditional culture-plate methods. Conventional microbial analyses require extensive manual operations. In addition, the necessity for visual determination of the growth of microbial colonies leads to longer assay times. Rapid microbial tests provide faster results, but the key to acceptance is staying consistent with the compendial method. The global pharmaceutical rapid microbiology testing market have been broadly segmented into immunology based methods, nucleic acid amplification tests, mass spectrometry based methods, flow cytometry based methods, growth based detection technologies and biochemical tests. The nucleic acid amplification tests are further segmented into polymerase chain reaction, nucleic acid sequence-based amplification and others. Growth based detection technologies are further classified into ATP-bioluminescence, colorimeter detection and auto-fluorescence detection. Nucleic acid amplification tests based methods held the largest share in the rapid microbiology market due to its wide application in the pharmaceutical industry. Moreover, low cost and high speed would further fuel the market growth of immunology based methods.
Pharmaceutical rapid microbiological tests are gaining momentum in the global market as a reliable and cost-effective method to track and monitor all types of microorganisms in pharmaceutical industry settings. The applications in the global pharmaceutical rapid microbiology testing market is segmented into raw material testing, in-process testing, microbial limit testing, bio burden assessment, process water testing, environmental monitoring, and sterility testing. The raw material testing application held the largest share in the global pharmaceutical rapid microbiology testing market due its wide application in the final drug product and other applications. Sterility testing is anticipated to witness the fastest growth in the global pharmaceutical rapid microbiology testing market.
Process water testing is anticipated to witness the highest growth
Rapid microbiological tests are gaining momentum in the global market as a reliable and cost-effective method to track and monitor all types of microorganisms in pharmaceutical industry settings. The applications in the global rapid microbiology tests in pharmaceutical industry market is segmented into raw material testing, in-process testing, microbial limit testing, bioburden assessment, process water testing, environmental monitoring, and sterility testing. The sterility testing application held the largest share in the global rapid microbiology tests in pharmaceutical market due its wide application in the final drug product and other applications. Process water testing is anticipated to witness the highest growth in the global rapid microbiology tests in the pharmaceutical industry market.Low cost and high speed would further fuel the market growth of immunology based methods
Rapid microbiology tests, also known as alternative microbiological methods, are the technologies that allow the user to get microbiology test results faster compared to the traditional culture-plate methods. Conventional microbial analyses require extensive manual operations. In addition, the necessity for visual determination of the growth of microbial colonies leads to longer assay times. Rapid microbial tests provide faster results, but the key to acceptance is staying consistent with the compendial method. The rapid microbiology tests have been broadly segmented into immunology based methods, nucleic acid amplification tests, mass spectrometry based methods, flow cytometry based methods, growth based detection technologies and biochemical tests. The nucleic acid amplification tests are further segmented into polymerase chain reaction, nucleic acid sequence-based amplification and others. Growth based detection technologies are further classified into ATP-bioluminescence, colorimeter detection and autoflurescence detection. Nucleic acid amplification tests based methods held the largest share in the rapid microbiology market due to its wide application in the pharmaceutical industry. Moreover, low cost and high speed would further fuel the market growth of immunology based methods.Asia Pacific is expected to grow at a highest rate
The geographical segmentation of the global rapid microbiology tests market comprises North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. In base year 2020, North America accounted for the largest market in the rapid microbiology tests market due to the presence of major life science companies in the region. Moreover, North America enhanced government initiatives to regulate the rapid microbiological testing in the industrial setting, especially in the pharmaceutical segment has further assisted the growth of rapid microbiology tests market in the region. Asia Pacific is expected to grow at a highest rate during the forecast period due to the population growth in the region, increasing awareness regarding product safety in the region. Rising investments by the major life science companies in the region would further fuel the growth of the rapid microbiology tests in pharmaceutical market in the region.Historical & Forecast Period
This report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Pharmaceutical Rapid Microbiology Testing market are as follows:- Research and development budgets of manufacturers and government spending.
- Revenues of key companies in the market segment.
- Number of end users and consumption volume, price and value.
- Geographical revenues generated by countries considered in the report.
- Micro and macro environment factors that are currently influencing the Pharmaceutical Rapid Microbiology Testing market and their expected impact during the forecast period.
- The market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Market Segmentation
Technology
- Immunology based Methods
- Nucleic acid based amplification tests
- Polymerase Chain Reaction
- Nucleic Acid Sequence-based amplification (NASBA)
- Others
- Mass Spectrometry based Methods
- Flow Cytometry based Methods
- Growth-based detection technologies
- ATP-bioluminescence
- Colorimeter detection
- Autofluorescence detection
- Biochemical Tests
Applications
- Raw material testing
- In-process testing
- Microbial limit testing
- Bioburden assessment
- Process water testing
- Environmental monitoring
- Sterility testing
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Pharmaceutical Rapid Microbiology Testing market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2030.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Pharmaceutical Rapid Microbiology Testing market?
- Which is the largest regional market for Pharmaceutical Rapid Microbiology Testing market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Pharmaceutical Rapid Microbiology Testing market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Pharmaceutical Rapid Microbiology Testing market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Pharmaceutical Rapid Microbiology Testing Market
2.2. Global Pharmaceutical Rapid Microbiology Testing Market, by Technology, 2021 (US$ Million)
2.3. Global Pharmaceutical Rapid Microbiology Testing Market, by Applications, 2021 (US$ Million)
2.4. Global Pharmaceutical Rapid Microbiology Testing Market, by Geography, 2021 (US$ Million)
2.5. Impact of COVID-19
2.6. Attractive Investment Proposition by Geography, 2021
2.7. Competitive Analysis
2.7.1. Market Positioning of Key Pharmaceutical Rapid Microbiology Testing Market Vendors
2.7.2. Strategies Adopted by Pharmaceutical Rapid Microbiology Testing Market Vendors
2.7.3. Key Industry Strategies
3. Pharmaceutical Rapid Microbiology Testing Market: Business Outlook & Market Dynamics
3.1. Introduction
3.2. Global Pharmaceutical Rapid Microbiology Testing Market Value, 2020-2030, (US$ Million)
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.2. Market Restraints
3.3.3. Key Challenges
3.3.4. Key Opportunities
3.4. Impact Analysis of Drivers and Restraints
3.5. See-Saw Analysis
3.6. Porter’s Five Force Model
3.6.1. Supplier Power
3.6.2. Buyer Power
3.6.3. Threat of Substitutes
3.6.4. Threat of New Entrants
3.6.5. Competitive Rivalry
3.7. PESTEL Analysis
3.7.1. Political Landscape
3.7.2. Economic Landscape
3.7.3. Technology Landscape
3.7.4. Legal Landscape
3.7.5. Social Landscape
4. Pharmaceutical Rapid Microbiology Testing Market: by Technology, 2020-2030, USD (Million)
4.1. Market Overview
4.2. Growth & Revenue Analysis: 2021 Versus 2030
4.3. Market Segmentation
4.3.1. Immunology based Methods
4.3.2. Nucleic acid based amplification tests
4.3.2.1. Polymerase Chain Reaction
4.3.2.2. Nucleic Acid Sequence-based amplification (NASBA)
4.3.2.3. Others
4.3.3. Mass Spectrometry based Methods
4.3.4. Flow Cytometry based Methods
4.3.5. Growth-based detection technologies
4.3.5.1. ATP-bioluminescence
4.3.5.2. Colorimeter detection
4.3.5.3. Autofluorescence detection
4.3.6. Biochemical Tests
5. Pharmaceutical Rapid Microbiology Testing Market: by Applications, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Raw material testing
5.3.2. In-process testing
5.3.3. Microbial limit testing
5.3.4. Bioburden assessment
5.3.5. Process water testing
5.3.6. Environmental monitoring
5.3.7. Sterility testing
6. North America Pharmaceutical Rapid Microbiology Testing Market, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Pharmaceutical Rapid Microbiology Testing Market: by Technology, 2020-2030, USD (Million)
6.3. Pharmaceutical Rapid Microbiology Testing Market: by Applications, 2020-2030, USD (Million)
6.4. Pharmaceutical Rapid Microbiology Testing Market: by Region, 2020-2030, USD (Million)
6.4.1. North America
6.4.1.1. U.S.
6.4.1.2. Canada
6.4.1.3. Rest of North America
7. UK and European Union Pharmaceutical Rapid Microbiology Testing Market, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Pharmaceutical Rapid Microbiology Testing Market: by Technology, 2020-2030, USD (Million)
7.3. Pharmaceutical Rapid Microbiology Testing Market: by Applications, 2020-2030, USD (Million)
7.4. Pharmaceutical Rapid Microbiology Testing Market: by Region, 2020-2030, USD (Million)
7.4.1. UK and European Union
7.4.1.1. UK
7.4.1.2. Germany
7.4.1.3. Spain
7.4.1.4. Italy
7.4.1.5. France
7.4.1.6. Rest of Europe
8. Asia Pacific Pharmaceutical Rapid Microbiology Testing Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Pharmaceutical Rapid Microbiology Testing Market: by Technology, 2020-2030, USD (Million)
8.3. Pharmaceutical Rapid Microbiology Testing Market: by Applications, 2020-2030, USD (Million)
8.4. Pharmaceutical Rapid Microbiology Testing Market: by Region, 2020-2030, USD (Million)
8.4.1. Asia Pacific
8.4.1.1. China
8.4.1.2. Japan
8.4.1.3. India
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Rest of Asia Pacific
9. Latin America Pharmaceutical Rapid Microbiology Testing Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Pharmaceutical Rapid Microbiology Testing Market: by Technology, 2020-2030, USD (Million)
9.3. Pharmaceutical Rapid Microbiology Testing Market: by Applications, 2020-2030, USD (Million)
9.4. Pharmaceutical Rapid Microbiology Testing Market: by Region, 2020-2030, USD (Million)
9.4.1. Latin America
9.4.1.1. Brazil
9.4.1.2. Mexico
9.4.1.3. Rest of Latin America
10. Middle East and Africa Pharmaceutical Rapid Microbiology Testing Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Pharmaceutical Rapid Microbiology Testing Market: by Technology, 2020-2030, USD (Million)
10.3. Pharmaceutical Rapid Microbiology Testing Market: by Applications, 2020-2030, USD (Million)
10.4. Pharmaceutical Rapid Microbiology Testing Market: by Region, 2020-2030, USD (Million)
10.4.1. Middle East and Africa
10.4.1.1. GCC
10.4.1.2. Africa
10.4.1.3. Rest of Middle East and Africa
11. Company Profiles
11.1. Abbott Laboratories, Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Alere, Inc.
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Bio-Rad Laboratories
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. Danaher Corporation
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Becton, Dickinson And Company
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. Gen-Probe, Inc.
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. F. Hoffman-La Roche AG
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. Orasure Technologies, Inc.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. Siemens Healthcare
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Thermo Fisher Scientific, Inc.
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives
11.11. Sysmex Corporation
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Portfolio
11.11.4. Strategic Initiatives
11.12. Other Notable Market Players
11.12.1. Company Overview
11.12.2. Financial Performance
11.12.3. Product Portfolio
11.12.4. Strategic InitiativesList of Figures
Figure 1. Global Pharmaceutical Rapid Microbiology Testing Market: Market Coverage
Figure 2. Research Methodology and Data Sources
Figure 3. Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4. Global Pharmaceutical Rapid Microbiology Testing Market: Quality Assurance
Figure 5. Global Pharmaceutical Rapid Microbiology Testing Market, By Technology, 2021
Figure 6. Global Pharmaceutical Rapid Microbiology Testing Market, By Applications, 2021
Figure 7. Global Pharmaceutical Rapid Microbiology Testing Market, By Geography, 2021
Figure 8. Global Pharmaceutical Rapid Microbiology Testing Market, By Technology, 2021 vs 2030, %
Figure 9. Global Pharmaceutical Rapid Microbiology Testing Market, By Applications, 2021 vs 2030, %
Figure 10. U.S. Pharmaceutical Rapid Microbiology Testing Market (US$ Million), 2020-2030
Figure 11. Canada Pharmaceutical Rapid Microbiology Testing Market (US$ Million), 2020-2030
Figure 12. Rest of North America Pharmaceutical Rapid Microbiology Testing Market (US$ Million), 2020-2030
Figure 13. UK Pharmaceutical Rapid Microbiology Testing Market (US$ Million), 2020-2030
Figure 14. Germany Pharmaceutical Rapid Microbiology Testing Market (US$ Million), 2020-2030
Figure 15. Spain Pharmaceutical Rapid Microbiology Testing Market (US$ Million), 2020-2030
Figure 16. Italy Pharmaceutical Rapid Microbiology Testing Market (US$ Million), 2020-2030
Figure 17. France Pharmaceutical Rapid Microbiology Testing Market (US$ Million), 2020-2030
Figure 18. Rest of Europe Pharmaceutical Rapid Microbiology Testing Market (US$ Million), 2020-2030
Figure 19. China Pharmaceutical Rapid Microbiology Testing Market (US$ Million), 2020-2030
Figure 20. Japan Pharmaceutical Rapid Microbiology Testing Market (US$ Million), 2020-2030
Figure 21. India Pharmaceutical Rapid Microbiology Testing Market (US$ Million), 2020-2030
Figure 22. Australia Pharmaceutical Rapid Microbiology Testing Market (US$ Million), 2020-2030
Figure 23. South Korea Pharmaceutical Rapid Microbiology Testing Market (US$ Million), 2020-2030
Figure 24. Rest of Asia Pharmaceutical Rapid Microbiology Testing Market (US$ Million), 2020-2030
Figure 25. Brazil Pharmaceutical Rapid Microbiology Testing Market (US$ Million), 2020-2030
Figure 26. Mexico Pharmaceutical Rapid Microbiology Testing Market (US$ Million), 2020-2030
Figure 27. Rest of Latin America Pharmaceutical Rapid Microbiology Testing Market (US$ Million), 2020-2030
Figure 28. GCC Pharmaceutical Rapid Microbiology Testing Market (US$ Million), 2020-2030
Figure 29. Africa Pharmaceutical Rapid Microbiology Testing Market (US$ Million), 2020-2030
Figure 30. Rest of Middle East and Africa Pharmaceutical Rapid Microbiology Testing Market (US$ Million), 2020-2030List of Tables
Table 1 Global Pharmaceutical Rapid Microbiology Testing Market by Technology, 2020-2030, USD (Million)
Table 2 Global Pharmaceutical Rapid Microbiology Testing Market by Nucleic acid based amplification tests, 2020-2030, USD (Million)
Table 3 Global Pharmaceutical Rapid Microbiology Testing Market by Growth-based detection technologies, 2020-2030, USD (Million)
Table 4 Global Pharmaceutical Rapid Microbiology Testing Market by Applications, 2020-2030, USD (Million)
Table 5 North America Pharmaceutical Rapid Microbiology Testing Market by Technology, 2020-2030, USD (Million)
Table 6 North America Pharmaceutical Rapid Microbiology Testing Market by Nucleic acid based amplification tests, 2020-2030, USD (Million)
Table 7 North America Pharmaceutical Rapid Microbiology Testing Market by Growth-based detection technologies, 2020-2030, USD (Million)
Table 8 North America Pharmaceutical Rapid Microbiology Testing Market by Applications, 2020-2030, USD (Million)
Table 9 UK and European Union Pharmaceutical Rapid Microbiology Testing Market by Technology, 2020-2030, USD (Million)
Table 10 UK and European Union Pharmaceutical Rapid Microbiology Testing Market by Nucleic acid based amplification tests, 2020-2030, USD (Million)
Table 11 UK and European Union Pharmaceutical Rapid Microbiology Testing Market by Growth-based detection technologies, 2020-2030, USD (Million)
Table 12 UK and European Union Pharmaceutical Rapid Microbiology Testing Market by Applications, 2020-2030, USD (Million)
Table 13 Asia Pacific Pharmaceutical Rapid Microbiology Testing Market by Technology, 2020-2030, USD (Million)
Table 14 Asia Pacific Pharmaceutical Rapid Microbiology Testing Market by Nucleic acid based amplification tests, 2020-2030, USD (Million)
Table 15 Asia Pacific Pharmaceutical Rapid Microbiology Testing Market by Growth-based detection technologies, 2020-2030, USD (Million)
Table 16 Asia Pacific Pharmaceutical Rapid Microbiology Testing Market by Applications, 2020-2030, USD (Million)
Table 17 Latin America Pharmaceutical Rapid Microbiology Testing Market by Technology, 2020-2030, USD (Million)
Table 18 Latin America Pharmaceutical Rapid Microbiology Testing Market by Nucleic acid based amplification tests, 2020-2030, USD (Million)
Table 19 Latin America Pharmaceutical Rapid Microbiology Testing Market by Growth-based detection technologies, 2020-2030, USD (Million)
Table 20 Latin America Pharmaceutical Rapid Microbiology Testing Market by Applications, 2020-2030, USD (Million)
Table 21 Middle East and Africa Pharmaceutical Rapid Microbiology Testing Market by Technology, 2020-2030, USD (Million)
Table 22 Middle East and Africa Pharmaceutical Rapid Microbiology Testing Market by Nucleic acid based amplification tests, 2020-2030, USD (Million)
Table 23 Middle East and Africa Pharmaceutical Rapid Microbiology Testing Market by Growth-based detection technologies, 2020-2030, USD (Million)
Table 24 Middle East and Africa Pharmaceutical Rapid Microbiology Testing Market by Applications, 2020-2030, USD (Million)
Companies Mentioned
- Abbott Laboratories Ltd.
- Alere Ltd.
- Bio-Rad Laboratories
- Danaher Corporation
- Becton
- Dickinson And Company
- Gen-Probe Ltd.
- F. Hoffman-La Roche AG
- Orasure Technologies Ltd.
- Siemens Healthcare
- Thermo Fisher Scientific Ltd.
- Sysmex Corporation
